newsfilter
← Latest News
ACCESS Newswire·

XPhyto Provides Progress Update on Psychedelic Medicine Programs and Novel Compounds Milestone

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / February 22, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to provide an update on its wholly owned subsidiary XPhyto Laboratories Inc. ("XPh